National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Biodefense and Related Programs
 Biodefense
 Radiation Countermeasures
 Chemical Countermeasures
  Introduction
  Research History
  Research Strategy
  Achievements and Goals
  Research Areas
   Cellular Respiration
   Nervous System
   Respiratory Tract
    Chemicals Affecting the Respiratory Tract
    Current Medical Countermeasures
    Potential Medical Countermeasures
    Short-Term Goals
    Long-Term Goals
   Skin, Eyes, and Mucous Membranes


Medical Countermeasures Against Chemical Threats

Respiratory Tract

Potential Medical Countermeasures

Although current treatments can be administered in a controlled hospital setting, many hospitals are ill-suited for a situation involving mass casualties among civilians. Inexpensive positive-pressure devices that can be used easily in a mass casualty situation, and drugs to prevent inflammation and pulmonary edema are needed. Several drugs that have been approved by the FDA for other indications hold promise for treating chemically induced pulmonary edema. These include β2-agonists, dopamine, insulin, allopurinol, and non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen. Ibuprofen is particularly appealing because it has an established safety record and can be easily administered as an initial intervention. Studies have shown that ibuprofen improves survival and reduces lung fluid levels in mice exposed to phosgene. Inhaled and systemic forms of β2-agonists used in the treatment of asthma and other commonly used medications, such as insulin, dopamine, and allopurinol have also been effective in reducing pulmonary edema in animal models but require further study.

Other promising drugs in earlier stages of development act at various steps in the complex molecular pathways underlying pulmonary edema. Some of these potential drugs target the inflammatory response or the specific site(s) of injury. Others modulate the activity of ion channels that control fluid transport across lung membranes or target surfactant, a substance that lines the air sacs in the lungs and prevents them from collapsing. Mechanistic information based on toxicology, biochemistry, and physiology may be instrumental in determining new targets for therapy.

Mechanistic studies may also aid in the development of new diagnostic approaches. Some chemicals generate metabolic byproducts that could be used for diagnosis, but detection of these byproducts may not be possible until many hours after initial exposure. Additional research needs to be directed at developing sensitive and specific tests to identify individuals quickly after they have been exposed to varying levels of chemicals toxic to the respiratory tract.

back to top


See Also

NIH Strategic Plan and Research Agenda for Medical Countermeasures Against Chemical Threats (PDF 3 MB)

Biodefense and Related Programs—The NIAID Biodefense Web site includes biodefense-related information for biomedical researchers, the public, and the media.

View a list of links for more information about Medical Countermeasures Against Chemical Threats

E-mail Icon E-mail this page
Print Icon Print this page
Plug-ins and Viewers
To open PDFs on this page, download and install the Adobe Acrobat Reader.

See Also

NIH Strategic Plan and Research Agenda for Medical Countermeasures Against Chemical Threats (PDF 3 MB)

Biodefense and Related Programs—The NIAID Biodefense Web site includes biodefense-related information for biomedical researchers, the public, and the media.

View a list of links for more information about Medical Countermeasures Against Chemical Threats